A Vitamin B supplement has been recalled due to being incorrectly formulated with niacin rather than niacinamide.
The US Food and Drug Administration (FDA) has approved Syndax Pharmaceuticals' Revuforj (revumenib) for treating relapsed or ...
Any changes Robert F. Kennedy Jr. wants to make will come up against a pharmaceutical industry that pays much of the U.S.
Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...
The product tested positive for Coliform, which are "considered indicators of fecal contamination and, thus, pathogenic ...
The U.S. Food and Drug Administration on Friday approved Syndax Pharmaceuticals' drug for the treatment of adult and ...
The FDA has just dropped a truth bomb: if you’ve been relying on those familiar red pills for a stuffy nose, it might be time ...
The U.S. Food and Drug Administration ( FDA) now requires TV and radio drug ads to be clearer and more direct. The new ...
The FDA’s REMS program has been found to have unintentionally created barriers to accessing clozapine, a crucial ...
The FDA spent more than 15 years crafting the guidelines, which are designed to do away with industry practices that downplay ...
These forward-looking statements may include statements regarding the expected timing of approval, if at all, of products by ...